| Literature DB >> 30733474 |
Hossein Derakhshankhah1,2, Atiyeh Hosseini3, Fereshteh Taghavi4, Samira Jafari2, Alireza Lotfabadi1,2,4, Mohammad Reza Ejtehadi5,6, Sahba Shahbazi7, Ali Fattahi2, Atiyeh Ghasemi4, Ebrahim Barzegari2, Mina Evini4, Ali Akbar Saboury4, Seyed Mehdi Kamali Shahri8, Behnaz Ghaemi9, Eng-Poh Ng10, Hussein Awala11, Fatemeh Omrani12, Iraj Nabipour12, Mohammad Raoufi13, Rassoul Dinarvand13, Koorosh Shahpasand14, Svetlana Mintova15, Mohammad Javad Hajipour16,17, Morteza Mahmoudi18.
Abstract
Fibrinogen is one of the key proteins that participate in the protein corona composition of many types of nanoparticles (NPs), and its conformational changes are crucial for activation of immune systems. Recently, we demonstrated that the fibrinogen highly contributed in the protein corona composition at the surface of zeolite nanoparticles. Therefore, understanding the interaction of fibrinogen with zeolite nanoparticles in more details could shed light of their safe applications in medicine. Thus, we probed the molecular interactions between fibrinogen and zeolite nanoparticles using both experimental and simulation approaches. The results indicated that fibrinogen has a strong and thermodynamically favorable interaction with zeolite nanoparticles in a non-cooperative manner. Additionally, fibrinogen experienced a substantial conformational change in the presence of zeolite nanoparticles through a concentration-dependent manner. Simulation results showed that both E- and D-domain of fibrinogen are bound to the EMT zeolite NPs via strong electrostatic interactions, and undergo structural changes leading to exposing normally buried sequences. D-domain has more contribution in this interaction and the C-terminus of γ chain (γ377-394), located in D-domain, showed the highest level of exposure compared to other sequences/residues.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30733474 PMCID: PMC6367512 DOI: 10.1038/s41598-018-37621-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(a) TEM image and DLS curve and (b) crystalline fringes representing the porosity of EMT zeolite NPs in the TEM. (c) Nitrogen adsorption (close symbols) and desorption (open symbols) isotherm of EMT zeolite NPs. Inset: Pore size distribution derived from nitrogen sorption analysis using DFT model. (d) Fluorescence intensity of fibrinogen in the presence of different concentrations of EMT zeolite NPs at 25, 37, 40 and 42 °C.
Physicochemical characteristics of EMT zeolite NPs.
| Si/Al ratio | 1.17 |
| Unit cell composition | Na88(AlO2)88(SiO2)104 |
| SBET (m2 g−1)a | 720 |
| SExt (m2 g−1)a | 260 |
| Vmicro (cm3 g−1)a | 0.24 |
| Vmeso (cm3 g−1)a | 1.08 |
| VTotal (cm3 g−1)a | 1.32 |
| dmicro (nm)a | 0.73 |
| dmeso (nm)a | 3.12 |
| Mean particle size (nm)b | 14.0 |
| Charge density (mC m−2)c | −6.05 |
| Surface charge (mC g−1)d | −4356 |
aSBET: BET specific surface area; Sext: external surface area; Vmicro: micropore volume; Vmeso: mesopore volume; Vtotal: total pore volume; dmicro: micropore diameter; dmeso: mesopore diameter.
bDetermined by DLS and TEM.
cDetermined at 0.1 wt% concentration.
dDetermined at 0.1 wt% concentration.
Figure 2(a) The Stern - Volmer plots of fibrinogen quenching caused by different concentrations of EMT zeolite NPs at different temperatures. (b) The double-log plots Log ((F0 − F)/F) vs. Log EMT for fibrinogen–EMT zeolite NPs interactions at different temperatures. (c) The Hill plots Ln (F0 − F)/F)) vs. Ln EMT for fibrinogen–EMT zeolite NPs interactions at physiological temperature (37 °C). (d) The van’t Hoff plots of fibrinogen–EMT zeolite NPs interactions. (e) CD spectra of fibrinogen molecules alone and in the presence of different concentrations of EMT zeolite NPs. (f) Secondary structural changes of fibrinogen in the presence of increasing concentrations of the EMT zeolite NPs. Results are mean ± standard error of mean (n = 20). Star represents significant change compared to control (Fibrinogen alone) at p < 0.05.
The Stern -Volmer constants calculated for fibrinogen–EMT zeolite NPs interactions.
| Zeolite | T (K) | Ksv (M−1) | Kq (M−1 S−1) | R2 |
|---|---|---|---|---|
| EMT NPs | 298.15 | 6280.4 | 6280.4 × 108 | 0.97 |
| 310.15 | 4532.3 | 4532.3 × 108 | 0.99 | |
| 313.15 | 3980.3 | 3980.3 × 108 | 0.99 | |
| 315.15 | 3611.9 | 3611.9 × 108 | 0.98 |
Binding parameters of fibrinogen–EMT zeolite NPs interactions at different temperatures.
| Zeolite | T (K) | Kα (M−1) |
| R2 |
|---|---|---|---|---|
| EMT NPs | 298.15 | 1216746.20 | 1.56 | 0.98 |
| 310.15 | 15595.52 | 1.13 | 0.99 | |
| 313.15 | 7184.55 | 1.06 | 0.99 | |
| 315.15 | 3322.76 | 0.99 | 0.98 |
Thermodynamic parameter involved in fibrinogen–EMT zeolite NPs interactions.
| Zeolite | T (K) | ΔG (kJ mol−1) |
|---|---|---|
| EMT NPs | 298.15 | −34.72 |
| 310.15 | −24.88 | |
| 313.15 | −23.11 | |
| 315.15 | −21.22 |
Figure 3Interactions between D-domain and EMT zeolite NPs at different stages of simulation and residues involved in this interaction.
Figure 4Interactions between E-domain and EMT zeolite NPs at different stages of simulation and residues involved in this interaction.
Figure 5Snapshots of different steps of D-domain (a–f) and E-domain (g–l) simulations without EMT zeolite NPs as a control for calculating RMSD, RMSF and ∆SASA.
Figure 6Root-mean-square deviation (RMSD) at equilibrium for (a) D-domain (b) and E-domain with/without EMT zeolite NPs. (c,d) Root-mean-square fluctuation (RMSF) per residue at equilibrium for D-domain-EMT zeolite and alone D-domain. These values are averaged over four simulations using each residue Cα for D-domain with/without zeolite. (e,f) RMSFs measured for the Cα of E-domain with/without zeolite.
Figure 7(a) Number of formed hydrogen bonds between D-domain and EMT zeolite NPs. (b) Number of formed hydrogen bonds between E-domain and EMT zeolite NPs. (c) Electrostatic and vdW energies between D-/E-domain and zeolite NPs. The important point is the difference between electrostatic energies of D-domain-EMT zeolite and E-domain-EMT zeolite which is about 4 kBT higher for D-domain.
Figure 8The differences of SASA for two setups (∆SASA = SASAD-/E-domain − SASAD-/E-domain- EMT zeolite) with error bars of 0.01 are presented to identify important residues exposed when D and E-domains of fibrinogen interact with EMT zeolite (for α, β and the γ chains). (a) The ∆SASA for α-chain of D-domain. (b) The ∆SASA for β-chain of D-domain. (c) The ∆SASA for γ-chain of D-domain. (d) The ∆SASA for α/β/γ-chains of D-domain. (e) The ∆SASA for α-chain of E-domain. (f) The ∆SASA for β-chain of E-domain. (g) The ∆SASA for γ-chain of E-domain. (h) The ∆SASA for α/β/γ-chains of E-domain. (i) For D-domain of fibrinogen, α-chain is colored in violet, β-chain is colored in green and γ-chain is colored in red. (j) For E-domain of fibrinogen, α-chain is colored in violet, β-chain is colored in green and γ-chain is colored in red.